Detalhe da pesquisa
1.
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Bioorg Med Chem Lett
; 22(16): 5303-7, 2012 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22795627
2.
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Bioorg Med Chem Lett
; 18(5): 1603-6, 2008 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18242991
3.
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.
J Med Chem
; 48(4): 909-12, 2005 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-15715460
4.
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.
J Med Chem
; 53(4): 1843-56, 2010 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-20102150
5.
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.
Bioorg Med Chem Lett
; 16(8): 2200-4, 2006 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16460935
6.
A novel series of potent and selective small molecule inhibitors of the complement component C1s.
Bioorg Med Chem Lett
; 14(12): 3043-7, 2004 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-15149641